Correlation Between Zealand Pharma and ALK Abell

Can any of the company-specific risk be diversified away by investing in both Zealand Pharma and ALK Abell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zealand Pharma and ALK Abell into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Zealand Pharma AS and ALK Abell AS, you can compare the effects of market volatilities on Zealand Pharma and ALK Abell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zealand Pharma with a short position of ALK Abell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zealand Pharma and ALK Abell.

Diversification Opportunities for Zealand Pharma and ALK Abell

0.83

Correlation Coefficient

Zealand Pharma  ALK Abell

Very poor diversification

The 3 months correlation between Zealand and ALK is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Zealand Pharma AS and ALK Abell AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ALK Abell AS and Zealand Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zealand Pharma AS are associated (or correlated) with ALK Abell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ALK Abell AS has no effect on the direction of Zealand Pharma i.e., Zealand Pharma and ALK Abell go up and down completely randomly.

Pair Corralation between Zealand Pharma and ALK Abell

Assuming the 90 days trading horizon Zealand Pharma AS is expected to under-perform the ALK Abell. In addition to that, Zealand Pharma is 2.86 times more volatile than ALK Abell AS. It trades about -0.05 of its total potential returns per unit of risk. ALK Abell AS is currently generating about -0.07 per unit of volatility. If you would invest  15,910  in ALK Abell AS on December 30, 2024 and sell it today you would lose (1,560) from holding ALK Abell AS or give up 9.81% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Zealand Pharma AS  vs.  ALK Abell AS

Zealand Pharma AS

Risk-Adjusted Performance

Very Weak

Over the last 90 days Zealand Pharma AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

ALK Abell AS

Risk-Adjusted Performance

Very Weak

Over the last 90 days ALK Abell AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Pair Trading with Zealand Pharma and ALK Abell

The main advantage of trading using opposite Zealand Pharma and ALK Abell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zealand Pharma position performs unexpectedly, ALK Abell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ALK Abell will offset losses from the drop in ALK Abell's long position.

The idea behind Zealand Pharma AS and ALK Abell AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.